Podcasts ·

Managing Cancer Metabolically Part 4: Stress, GKI & Patient Empowerment

Talking Cancer with Professor Thomas Seyfried

In Part 4 of this ongoing conversation, Dr. Donese Worden joins Professor Thomas Seyfried to explore the practical side of metabolic cancer therapy—from managing stress and blood sugar to patient self-advocacy, scientific literacy, and the future of metabolic oncology research.

The discussion also looks ahead to new research from Professor Seyfried’s lab and the growing role of the M.O.R.E. Alliance (Metabolic Oncology Research & Education Alliance) in translating metabolic oncology science into education for clinicians, patients, and the public.

Related Episodes:

Stress, Blood Sugar and the Glucose Ketone Index (GKI)

Dr. Worden and Professor Seyfried discuss why stress management matters in ketogenic metabolic therapy, including the relationship between stress and blood glucose. They also preview upcoming work involving Glucose Ketone Index (GKI) zones and the use of measurable metabolic markers to better understand therapeutic ketosis.

Doing Ketogenic Metabolic Therapy in Real Life

The conversation moves from research into everyday application, including the foods Dr. Worden and Professor Seyfried personally turn to when following a ketogenic approach. They also discuss alcohol, sleep, and the importance of looking at the whole person rather than focusing on a single metabolic number.

Dare to Doubt: Patient Empowerment and Self-Advocacy

Dr. Worden introduces her “Dare to Doubt” philosophy as a call for patients to question dogma, ask better questions, and become active participants in their healthcare. The goal is not to reject expertise, but to develop the knowledge and confidence needed to advocate for yourself when navigating complex medical decisions.

From the Genetic Theory to the Metabolic Theory of Cancer

Professor Seyfried reflects on the scientific path that led his research from genetics toward metabolism, including the influence of Otto Warburg’s work and research involving epilepsy and ketogenic therapy. The discussion examines why the metabolic theory of cancer continues to challenge established thinking about cancer biology.

Reducing Fear and Changing the Cancer Conversation

Dr. Worden and Professor Seyfried discuss the importance of reducing fear around a cancer diagnosis and helping patients understand that they can take an active role in their care. Scientific literacy, education, and a clearer understanding of metabolic health can help patients approach difficult decisions with greater confidence.

The M.O.R.E. Alliance and the Future of Metabolic Oncology

The episode concludes with updates on the M.O.R.E. Alliance and upcoming research from Professor Seyfried’s lab, including work involving pediatric high-grade glioma and efforts to make metabolic oncology research understandable to younger and non-scientific audiences.

Through research, education, and greater scientific literacy, the M.O.R.E. Alliance aims to help bridge the gap between metabolic oncology research and its practical application in patient care.

In This Interview You'll Learn

  • How stress and blood sugar can affect the Glucose Ketone Index (GKI)
  • Why GKI zones may help patients and clinicians better understand metabolic therapy
  • How ketogenic metabolic principles translate into everyday food and lifestyle choices
  • Why “Dare to Doubt” and patient self-advocacy matter in cancer care
  • How Professor Seyfried’s research moved from genetics toward the metabolic theory of cancer
  • Why reducing fear and improving scientific literacy are important for patients
  • How the M.O.R.E. Alliance plans to advance metabolic oncology research and education

Watch the full interview above to hear Dr. Donese Worden and Professor Thomas Seyfried discuss the practical realities of metabolic cancer therapy, patient empowerment, and what comes next for metabolic oncology research and the M.O.R.E. Alliance.

Back to Media Center